/Passle/5e8c58ad3dccd208784b45a3/MediaLibrary/Images/2024-10-15-19-53-27-360-670ec837dd71ccaa0996a993.png)
Edwards Lifesciences Corp. (Edwards) abandoned its $945 million acquisition of JenaValve Technology, Inc. (JenaValve) after the U.S....
A Fresh Take
Insights on US legal developments
With the stock market trending up and sustained high interest rates for debt financing, many acquirors are using their stock as...
Approximately 8% of the S&P 500 and 9.4% of the Russell 3000 have multi-class share structures with uneven voting rights between or among...
In the fourth quarter of 2025, Novo Nordisk tried a novel structure for making a “superior proposal” as an interloper to top Pfizer’s...
The MedTech industry is entering 2026 at a pivotal moment. Regulatory complexities, geopolitical tensions, and persistent supply chain...
The 44th Annual J.P. Morgan Healthcare Conference concluded last week in San Francisco. In general, we noted a cautiously optimistic...
Here’s a quick overview of the new challenges and issues that I’m predicting the M&A eco-system will face in the coming year: Antitrust –...
Freshfields U.S. government contracts Counsel Nathaniel E. Castellano published an article on mergers and acquisitions involving...
As big pharmas and other commercial-stage biopharma and biotech companies grapple with the reality of patent cliffs on the horizon, which...
About two years ago, we wrote a post about a series of high-profile M&A cases in the Delaware Court of Chancery that highlighted the...
/Passle/5e8c58ad3dccd208784b45a3/MediaLibrary/Images/2025-05-20-17-56-03-311-682cc2337f300619aaccb39a.png)
Thank you to the in-person attendees who packed the “sold-out” venue and the hundreds who joined virtually at the 11th Annual Spring...
Delaware’s entire fairness doctrine – response to which in part drove the SB 21 amendments to Delaware corporate law enacted on March 25,...